FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288059293> ?p ?o ?g. }

• W4288059293 endingPage "556" @default.
• W4288059293 startingPage "549" @default.
• W4288059293 abstract "To analyze the correlation between glycocalyx disruption measured via the serum syndecan-1 level and organ dysfunctions assessed by the PELOD-2 score and to evaluate its association with mortality in pediatric sepsis.We performed a prospective observational study in a tertiary public hospital. Sixty-eight pediatric patients diagnosed with sepsis according to International Pediatric Sepsis Consensus Conference criteria were consecutively recruited. We performed measurements of day 1 and day 5 serum syndecan-1 levels and PELOD-2 score components. Patients were followed up to 28 days following sepsis diagnosis.Overall, the syndecan-1 level was increased in all subjects, with a significantly higher level among septic shock patients (p = 0.01). The day 1 syndecan-1 level was positively correlated with the day 1 PELOD-2 score with a correlation coefficient of 0.35 (p = 0.003). Changes in syndecan-1 were positively correlated with changes in the PELOD-2 score, with a correlation coefficient of 0.499 (p < 0.001) during the first five days. Using the cutoff point of day 1 syndecan-1 ≥ 430ng/mL, organ dysfunction (PELOD-2 score of ≥ 8) could be predicted with an AUC of 74.3%, sensitivity of 78.6%, and specificity of 68.5% (p = 0.001).The day 1 syndecan-1 level was correlated with the day 1 PELOD-2 score but not 28-day mortality. Organ dysfunction (PELOD-2 ≥ 8) could be predicted by the syndecan-1 level in the first 24 hours of sepsis, suggesting its significant pathophysiological involvement in sepsis-associated organ dysfunction.Analisar a correlação entre a lesão do glicocálix medida pelo nível sérico de sindecano 1 e as disfunções de órgãos avaliadas com o escore PELOD-2, assim como avaliar sua associação com a mortalidade em sepse pediátrica.Realizou-se um estudo prospectivo observacional em um hospital terciário público. Sessenta e oito pacientes pediátricos, com diagnóstico de sepse segundo os critérios da International Pediatric Sepsis Consensus Conference, foram consecutivamente recrutados. Nos dias 1 e 5, realizaram-se dosagens dos níveis séricos de sindecano 1 e avaliação dos componentes do escore PELOD-2. Os pacientes foram seguidos por até 28 dias após o diagnóstico de sepse.Em geral, o nível de sindecano 1 estava aumentado em todos os participantes, com nível significantemente mais elevado nos pacientes em choque (p = 0,01). O nível de sindecano 1 no dia 1 teve correlação positiva com o escore PELOD-2 no dia 1 e coeficiente de correlação de 0,35 (p = 0,003). Nos primeiros 5 dias após o diagnóstico de sepse, as alterações nos níveis de sindecano 1 tiveram correlação positiva com modificações no escore PELOD-2, com coeficiente de correlação de 0,499 (p < 0,001). Com utilização de um ponto de corte dos níveis de sindecano 1 no dia 1 ≥ 430ng/mL, a disfunção de órgãos (escore PELOD-2 ≥ 8) pôde ser predita com área sob a curva de 74,3%, sensibilidade de 78,6% e especificidade de 68,5% (p = 0,001).O nível de sindecano 1 no dia 1 teve correlação com o escore PELOD-2 no dia 1, porém não se associou com a mortalidade aos 28 dias. A disfunção de órgãos (PELOD-2 ≥ 8) pôde ser predita pelo nível de sindecano 1 nas primeiras 24 horas de sepse, sugerindo seu significante envolvimento na fisiopatologia da disfunção de órgãos associada à sepse." @default.
• W4288059293 created "2022-07-28" @default.
• W4288059293 creator A5001010122 @default.
• W4288059293 creator A5045278039 @default.
• W4288059293 creator A5086988709 @default.
• W4288059293 date "2022-01-01" @default.
• W4288059293 modified "2023-10-18" @default.
• W4288059293 title "Correlation between syndecan-1 level and PELOD-2 score and mortality in pediatric sepsis." @default.
• W4288059293 cites W1578062386 @default.
• W4288059293 cites W1887527618 @default.
• W4288059293 cites W1981940713 @default.
• W4288059293 cites W1986727315 @default.
• W4288059293 cites W1988148664 @default.
• W4288059293 cites W2010714117 @default.
• W4288059293 cites W2015329932 @default.
• W4288059293 cites W2018763717 @default.
• W4288059293 cites W2046044305 @default.
• W4288059293 cites W2052233685 @default.
• W4288059293 cites W2067535945 @default.
• W4288059293 cites W2076590961 @default.
• W4288059293 cites W2085382520 @default.
• W4288059293 cites W2110971703 @default.
• W4288059293 cites W2111265958 @default.
• W4288059293 cites W2112223256 @default.
• W4288059293 cites W2124216717 @default.
• W4288059293 cites W2143965055 @default.
• W4288059293 cites W2190576756 @default.
• W4288059293 cites W2289813931 @default.
• W4288059293 cites W2581605534 @default.
• W4288059293 cites W2767777889 @default.
• W4288059293 cites W2779809707 @default.
• W4288059293 cites W2788388954 @default.
• W4288059293 cites W3004427938 @default.
• W4288059293 doi "https://doi.org/10.5935/0103-507x.20210083" @default.
• W4288059293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35081239" @default.
• W4288059293 hasPublicationYear "2022" @default.
• W4288059293 type Work @default.
• W4288059293 citedByCount "1" @default.
• W4288059293 countsByYear W42880592932022 @default.
• W4288059293 crossrefType "journal-article" @default.
• W4288059293 hasAuthorship W4288059293A5001010122 @default.
• W4288059293 hasAuthorship W4288059293A5045278039 @default.
• W4288059293 hasAuthorship W4288059293A5086988709 @default.
• W4288059293 hasConcept C117220453 @default.
• W4288059293 hasConcept C126322002 @default.
• W4288059293 hasConcept C1491633281 @default.
• W4288059293 hasConcept C2524010 @default.
• W4288059293 hasConcept C2778384902 @default.
• W4288059293 hasConcept C2778426790 @default.
• W4288059293 hasConcept C2780835948 @default.
• W4288059293 hasConcept C33923547 @default.
• W4288059293 hasConcept C54355233 @default.
• W4288059293 hasConcept C65001120 @default.
• W4288059293 hasConcept C71924100 @default.
• W4288059293 hasConcept C86803240 @default.
• W4288059293 hasConcept C90924648 @default.
• W4288059293 hasConceptScore W4288059293C117220453 @default.
• W4288059293 hasConceptScore W4288059293C126322002 @default.
• W4288059293 hasConceptScore W4288059293C1491633281 @default.
• W4288059293 hasConceptScore W4288059293C2524010 @default.
• W4288059293 hasConceptScore W4288059293C2778384902 @default.
• W4288059293 hasConceptScore W4288059293C2778426790 @default.
• W4288059293 hasConceptScore W4288059293C2780835948 @default.
• W4288059293 hasConceptScore W4288059293C33923547 @default.
• W4288059293 hasConceptScore W4288059293C54355233 @default.
• W4288059293 hasConceptScore W4288059293C65001120 @default.
• W4288059293 hasConceptScore W4288059293C71924100 @default.
• W4288059293 hasConceptScore W4288059293C86803240 @default.
• W4288059293 hasConceptScore W4288059293C90924648 @default.
• W4288059293 hasIssue "4" @default.
• W4288059293 hasLocation W42880592931 @default.
• W4288059293 hasLocation W42880592932 @default.
• W4288059293 hasOpenAccess W4288059293 @default.
• W4288059293 hasPrimaryLocation W42880592931 @default.
• W4288059293 hasRelatedWork W12274878 @default.
• W4288059293 hasRelatedWork W12742693 @default.
• W4288059293 hasRelatedWork W16969989 @default.
• W4288059293 hasRelatedWork W17396769 @default.
• W4288059293 hasRelatedWork W17689944 @default.
• W4288059293 hasRelatedWork W18902251 @default.
• W4288059293 hasRelatedWork W21104736 @default.
• W4288059293 hasRelatedWork W4425275 @default.
• W4288059293 hasRelatedWork W8838715 @default.
• W4288059293 hasRelatedWork W9360305 @default.
• W4288059293 hasVolume "33" @default.
• W4288059293 isParatext "false" @default.
• W4288059293 isRetracted "false" @default.
• W4288059293 workType "article" @default.